Delivery Order SPE2DR25D3401-SPE2DR26FL0QL
- Not listed
- The Defense Logistics Agency awarded a $1,281.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6-count). The contract is non-set-aside and competitively awarded, with a completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which falls...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three, with a ceiling value of $4,829.14. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6-count format) under a firm fixed-price contract valued at $11,572.48. The award was made on November 10, 2025, with an ultimate completion date of November 12, 2025, and is classified as a non-set-aside, competitively awarded delivery order. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as both the place...
- The Defense Logistics Agency awarded a $3,118.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Zolmitriptan 2.5 mg oral disintegrating tablets in unit dose packaging (6 count). The contract is classified as non-set-aside and carries an ultimate completion date of November 6, 2025, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under the company's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,215.11 to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packages of six on August 11, 2025. This firm fixed price delivery order, which is expected to be completed by August 12, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,146.54 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5mg in a 6-count package. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and due for completion by December 16, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- This delivery order, awarded August 8, 2025, by the Defense Logistics Agency's Medical Supply Chain, procures Zolmitriptan 2.5 mg oral disintegrating tablets (unit dose, 6-count packages) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The firm fixed price delivery order, valued at $1,334.50, is scheduled for completion by August 11, 2025, with performance occurring at the vendor's Conshohocken facility. The award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packaging. This competitive award, valued at $1,613.03 with a firm fixed price structure, represents a single delivery order without set-aside designation. The contract is scheduled for completion on October 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,306.66 to AmerisourceBergen Drug Corp for Zolmitriptan 5mg ODT (orally disintegrating tablets) in quantities of 3 units. The award, issued on November 26, 2025, with a completion date of December 24, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, which serves as the...
- The Defense Logistics Agency awarded a $18,142.31 delivery order to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg tablets in unit dose packages of 6, with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical procurement supporting federal healthcare operations. The contract is executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D3401Indefinite Delivery Contract
- SPE2DR25D3401-SPE2DR26FL0QLDelivery Order
The Defense Logistics Agency awarded a $8,776.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (six count). The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by December 12, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement valued through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical supply vendor with an extensive portfolio of pharmaceutical products and medical commodities. The company's DLA prime vendor contract encompasses a broad range of medications and medical supplies across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. The current delivery order for Zolmitriptan—a migraine treatment medication—represents a routine procurement transaction consistent with AmerisourceBergen's established role as a primary pharmaceutical supplier for federal military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 12/10/25 |